Dr Chris G Roberts
> CEO/President > BE (Hons), MBA, PhD, FAICD, FTSE

Chief Executive Officer of Cochlear Limited. Director of ResMed Inc since 1992 and Chairman of Research Australia. Member of the National Health and Medical Research Council. Dr Roberts has worked in the medical device industry for more than 29 years in a number of senior management positions.

Richard Brook
> President, European Region > BSc Management, MBA

Joined Cochlear in 2003 with 15 years prior experience in the medical device industry, including with Guidant Corporation. Previous roles include responsibility for direct and distributor operations in Europe, the Middle East, South Africa and Australasia in sales, marketing, customer and technical service functions.

Dig Howitt
> Senior Vice President, Manufacturing and Logistics > BE (Hons), MBA

Joined Cochlear in 2000. Has more than 10 years experience in general management with Sunstate Cement Ltd and management consulting with Boston Consulting Group focusing on strategy development and operational improvement.

Jan Janssen
> Senior Vice President, Design and Development > MScEE

Joined Cochlear in 2000 as General Manager of the Cochlear Technology Centre. Commenced role of Senior Vice President, Design and Development in May 2005. Has 15 years experience in research and development with involvement in fields of high technology electronics and cochlear implants.

Michael Kavanagh
> Senior Vice President, Global Marketing > BSc, MBA (Advanced)

Joined Cochlear in 2003. Has more than 15 years experience in the healthcare industry working in senior sales and marketing positions both locally and internationally.

Marg Lennon
> Vice President, Human Resources and Organisation Development

Joined Cochlear in 2001. Has 16 years experience in human resources working for Merck specialising in the fields of learning and development, organisational effectiveness and organisational development.

Neville Mitchell
> Chief Financial Officer and Company Secretary > BComm, CA (SA), CA

Joined Cochlear in 1990 as Financial Controller, became Chief Financial Officer and Company Secretary following listing in 1995. Former Senior Manager with KPMG, Johannesburg.

David Morris
> President, Bone Anchored Solutions > BBus, BAppSc

Joined Cochlear in 2002. Has extensive experience in strategy and operational consulting with a global technology and management consulting company working in the consumer products, pharmaceutical, financial services and utilities industries throughout Asia Pacific, the United States and Europe.

Dr Adrian Oates
> Vice President, Quality and Regulatory > BSc, MSc Prelim, PhD

Joined Cochlear in 2004. Has 17 years experience in the healthcare industry across quality, regulatory, research and development and project management. Previously Quality Director at CSL Bioplasma.

Dr John L Parker
> Senior Vice President, Chief Technology Officer > BSc (Hons), PhD, DOC

Chief Technology Officer of Cochlear Limited. Director of Premier Bionics Limited since 2004. Governor of the Warren Centre for Advanced Engineering, Board member of the Cooperative Research Centre for Cochlear Implants and Hearing Innovation. Has an academic appointment as a Visiting Fellow at the Department of Maths, Physics, Computing and Electronics at Macquarie University, NSW.

Jim Patrick
> Senior Vice President, Chief Scientist > MSc

One of the original Cochlear team in 1981. Deputy Director of the Cooperative Research Centre for Cochlear Implant and Hearing Aid Innovation and Associate Professor, Department of Otolaryngology, The University of Melbourne.

Mark Salmon
> President, Asia Pacific Region > MBA

Joined Cochlear in July 2004. Has more than 20 years experience in the medical industry. Previously President and CEO of Asia Growth Markets and Australia, New Zealand and South East Asia for GE Medical Systems.

Chris Smith
> President, Americas Region > BSc

Joined Cochlear in August 2004. Has more than 20 years experience in the medical device industry specifically, and healthcare in general in the United States including assisting Warburg Pincus, a direct equity healthcare investor in identifying market opportunities for investment. Prior to this, was Group President for Gyrus Group (ENT and Surgical Divisions).